Summit Therapeutics Trading Near 52-Week Low
Summit Therapeutics (NASDAQ: SMMT) is a notable publicly traded company with a market cap exceeding $10 billion, yet it has ...
Summit Therapeutics (NASDAQ: SMMT) is a notable publicly traded company with a market cap exceeding $10 billion, yet it has ...
Vera Therapeutics (NASDAQ: VERA) experienced a notable increase in its stock price, closing 13% higher on Wednesday, following a positive ...
Cidara Therapeutics (NASDAQ: CDTX) saw its stock rise nearly 7% on Friday, significantly outperforming the S&P 500's 0.6% increase, following ...
Shares of clinical-stage biotech CytomX Therapeutics (NASDAQ: CTMX) surged by 43% this week following analyst Olivia Brayer from Cantor Fitzgerald ...
Relay Therapeutics (NASDAQ: RLAY) experienced a nearly 15% increase in its stock price during a holiday-shortened trading week, driven by ...
One day before the July Fourth holiday, shares of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) surged by 8% following a ...
In this episode of the Motley Fool Scoreboard, expert analysts delve into the dynamic realm of Axsome Therapeutics (NASDAQ: AXSM), ...
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.